|
1
|
Forman D: Helicobacter pylori and gastric
cancer. Scand J Gastroenterol Suppl. 215:48–51. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nunobe S, Sasako M, Saka M, Fukagawa T,
Katai H and Sano T: Symptom evaluation of long-term postoperative
outcomes after pylorus-preserving gastrectomy for early gastric
cancer. Gastric Cancer. 10:167–172. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Araya M, Terashima M, Takagane A, Abe K,
Nishizuka S, Yonezawa H, Irinoda T, Nakaya T and Saito K:
Microvessel count predicts metastasis and prognosis in patients
with gastric cancer. J Surg Oncol. 65:232–236. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu S, Feng F, Xu G, Liu Z, Tian Y, Guo M,
Lian X, Cai L, Fan D and Zhang H: Clinicopathological features and
prognosis of gastric cancer in young patients. BMC Cancer.
16:4782016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
de Martel C, Forman D and Plummer M:
Gastric cancer: Epidemiology and risk factors. Gastroenterol Clin
North Am. 42:219–240. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mcguire S: World Cancer Report 2014.
Geneva, Switzerland: World health organization, international
agency for research on cancer, WHO Press, 2015. Adv Nutr.
7:418–419. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Jian-bo X, Hui W, Yu-long H, Chang-hua Z,
Long-juan Z, Shi-rong C and Wen-hua Z: Astrocyte-elevated gene-1
overexpression is associated with poor prognosis in gastric cancer.
Med Oncol. 28:455–462. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun J, Ling B, Xu X, Ma R, Li G, Cao X,
Ling W, Yang Z, Hoffman RM and Lu J: Decreased expression of
tumor-suppressor gene LKB1 correlates with poor prognosis in human
gastric cancer. Anticancer Res. 36:869–875. 2016.PubMed/NCBI
|
|
9
|
Ma LG, Bian SB, Cui JX, Xi HQ, Zhang KC,
Qin HZ, Zhu XM and Chen L: LKB1 inhibits the proliferation of
gastric cancer cells by suppressing the nuclear translocation of
Yap and β-catenin. Int J Mol Med. 37:1039–1048. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
You X, Ma M, Hou G, Hu Y and Shi X: Gene
expression and prognosis of NOX family members in gastric cancer.
Onco Targets Ther. 11:3065–3074. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Han M, Ma L, Qu Y and Tang Y: Decreased
expression of the ATM gene linked to poor prognosis for gastric
cancer of different nationalities in Xinjiang. Pathol Res Pract.
213:908–914. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Feng L, Yao C, Li P, Feng Y, Wang F, Liu
YF, Guo YB, Mao QS and Xue WJ: Low expression of fibulin-1
correlates with unfavorable prognosis in gastric cancer. Tumor
Biol. 37:9399–9410. 2016. View Article : Google Scholar
|
|
13
|
Baĭramov RB and Abdullaeva RT: The impact
of early gastric cancer diagnosis on indices of survival in
patients after radical surgical intervention. Klin Khir. 18–21.
2013.(In Russian).
|
|
14
|
Kim JW, Hwang I, Kim MJ and Jang SJ:
Clinicopathological characteristics and predictive markers of early
gastric cancer with recurrence. J Korean Med Sci. 24:1158–1164.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu X, Cai H and Wang Y: Prognostic
significance of tumor markers in T4a gastric cancer. World J Surg
Oncol. 10:682012. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cho JY, Lim JY, Cheong JH, Park YY, Yoon
SL, Kim SM, Kim SB, Kim H, Hong SW, Park YN, et al: Gene expression
signature-based prognostic risk score in gastric cancer. Clin
Cancer Res. 17:1850–1857. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang Z, Yan Z, Zhang B, Rao Z, Zhang Y,
Liu J, Yu L, Zhao Y, Yang B, Wu T and Gao J: Identification of a
5-gene signature for clinical and prognostic prediction in gastric
cancer patients upon microarray data. Med Oncol. 30:6782013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Shen J, Wei J, Wang H, Yue G, Yu L, Yang
Y, Xie L, Zou Z, Qian X, Ding Y, et al: A three-gene signature as
potential predictive biomarker for irinotecan sensitivity in
gastric cancer. J Transl Med. 11:732013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Wang P, Wang Y, Hang B, Zou X and Mao JH:
A novel gene expression-based prognostic scoring system to predict
survival in gastric cancer. Oncotarget. 7:55343–55351.
2016.PubMed/NCBI
|
|
20
|
Zhao X, Cai H, Wang X and Ma L: Discovery
of signature genes in gastric cancer associated with prognosis.
Neoplasma. 63:239–245. 2016.PubMed/NCBI
|
|
21
|
Hou JY, Wang YG, Ma SJ, Yang BY and Li QP:
Identification of a prognostic 5-Gene expression signature for
gastric cancer. J Cancer Res Clin Oncol. 143:619–629. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Wang Z, Chen G, Wang Q, Lu W and Xu M:
Identification and validation of a prognostic 9-genes expression
signature for gastric cancer. Oncotarget. 8:73826–73836.
2017.PubMed/NCBI
|
|
23
|
Li Y, Yu Q, Zhu R, Wang Y, Li J, Wang Q,
Guo W, Fu S and Zhu L: A six-gene signature predicts clinical
outcome of gastric adenocarcinoma. Comb Chem High Throughput
Screen. 21:444–452. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Deng X, Xiao Q, Liu F and Zheng C: A gene
expression-based risk model reveals prognosis of gastric cancer.
PeerJ. 6:e42042018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Min L, Zhao Y, Zhu S, Qiu X, Cheng R, Xing
J, Shao L, Guo S and Zhang S: Integrated analysis identifies
molecular signatures and specific prognostic factors for different
gastric cancer subtypes. Transl Oncol. 10:99–107. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Wang J, Gao P, Sun J and Shi J: A six-gene
prognostic predictor for patients with gastric cancer. Oncotarget.
5:2018.
|
|
27
|
Kim S, Lim DH, Lee J, Kang WK, MacDonald
JS, Park CH, Park SH, Lee SH, Kim K, Park JO, et al: An
observational study suggesting clinical benefit for adjuvant
postoperative chemoradiation in a population of over 500 cases
after gastric resection with D2 nodal dissection for adenocarcinoma
of the stomach. Int J Radiat Oncol Biol Phys. 63:1279–1285. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yoo CH, Noh SH, Shin DW, Choi SH and Min
JS: Recurrence following curative resection for gastric carcinoma.
Br J Surg. 87:236–242. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Cristescu R, Lee J, Nebozhyn M, Kim KM,
Ting JC, Wong SS, Liu J, Yue YG, Wang J, Yu K, et al: Molecular
analysis of gastric cancer identifies subtypes associated with
distinct clinical outcomes. Nat Med. 21:449–456. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lee J, Sohn I, Do IG, Kim KM, Park SH,
Park JO, Park YS, Lim HY, Sohn TS, Bae JM, et al: Nanostring-based
multigene assay to predict recurrence for gastric cancer patients
after surgery. PLoS One. 9:e901332014. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Therneau TM: A Package for Survival
Analysis in S. R package version 2.41–3. http://cran.nexr.com/web/packages/survival/index.html
|
|
32
|
Kouznetsov D and Trappmann H:
Superfunctions and sqrt of factorial. Moscow Univ Phys Bull.
65:6–12. 2010. View Article : Google Scholar
|
|
33
|
Ritchie ME, Phipson B, Wu D, Hu Y, Law CW,
Shi W and Smyth GK: limma powers differential expression analyses
for RNA-sequencing and microarray studies. Nucleic Acids Res.
43:e472015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
He X, Tan X, Wang X, Jin H, Liu L, Ma L,
Yu H and Fan Z: C-Myc-activated long noncoding RNA CCAT1 promotes
colon cancer cell proliferation and invasion. Tumor Biol.
35:12181–12188. 2014. View Article : Google Scholar
|
|
35
|
Kuhn M: Building predictive models in R
using the caret package. J Stat Software. 28:1–26. 2008. View Article : Google Scholar
|
|
36
|
Mavroforakis ME and Theodoridis S: Support
Vector Machine (SVM) classification through geometry. Proceedings
of the 2005 13th European Signal Processing Conference. IEEE;
Antalya: pp. 1–4. 2013
|
|
37
|
Meyer D: Support vector machines the
interface to libsvm in package e1071. R News. 1:1–3. 2013.
|
|
38
|
Schröder MS, Culhane AC, Quackenbush J and
Haibe-Kains B: Survcomp: An R/Bioconductor package for performance
assessment and comparison of survival models. Bioinformatics.
27:3206–3208. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Kalderstam J, Edén P, Bendahl PO, Strand
C, Fernö M and Ohlsson M: Training artificial neural networks
directly on the concordance index for censored data using genetic
algorithms. Artif Intell Med. 58:125–132. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Ferro CAT and Fricker TE: A bias-corrected
decomposition of the Brier score. Quarterly J Royal Meteorological
Soc. 138:1954–1960. 2012. View Article : Google Scholar
|
|
41
|
Robin X, Turck N, Hainard A, Tiberti N,
Lisacek F, Sanchez JC and Müller M: pROC: An open-source package
for R and S+ to analyze and compare ROC curves. BMC Bioinformatics.
12:772011. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ripatti S and Palmgren J: Estimation of
multivariate frailty models using penalized partial likelihood.
Biometrics. 56:1016–1022. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Alexeyenko A, Lee W, Pernemalm M, Guegan
J, Dessen P, Lazar V, Lehtiö J and Pawitan Y: Network enrichment
analysis: Extension of gene-set enrichment analysis to gene
networks. BMC Bioinformatics. 13:2262012. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Choi MC, Jong HS, Kim TY, Song SH, Lee DS,
Lee JW, Kim TY, Kim NK and Bang YJ: AKAP12/Gravin is inactivated by
epigenetic mechanism in human gastric carcinoma and shows growth
suppressor activity. Oncogene. 23:7095–7103. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Choi MC, Lee YU, Kim SH, Park JH, Kim HA,
Oh DY, Im SA, Kim TY, Jong HS and Bang YJ: A-kinase anchoring
protein 12 regulates the completion of cytokinesis. Biochem Biophys
Res Commun. 373:85–89. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Shimura T, Tanaka K, Saigusa S, Kondo S,
Kitajima T, Toiyama Y, Okugawa Y, Inoue Y, Araki TH, Uchida K, et
al: Abstract 1139: Prognostic value of angiopoietin-like protein 2
(ANGPTL2) at the tumor margins in patients with gastric cancer.
Cancer Res. 73:11392013.
|
|
47
|
Sheng WZ, Chen YS, Tu CT, He J, Zhang B
and Gao WD: ANGPTL2 expression in gastric cancer tissues and cells
and its biological behavior. World J Gastroenterol. 22:10364–10370.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Shimura T, Toiyama Y, Tanaka K, Saigusa S,
Kitajima T, Kondo S, Okigami M, Yasuda H, Ohi M, Araki T, et al:
Angiopoietin-like protein 2 as a predictor of early recurrence in
patients after curative surgery for gastric cancer. Anticancer Res.
35:4633–4639. 2015.PubMed/NCBI
|
|
49
|
Tiberio P, Lozneanu L, Angeloni V,
Cavadini E, Pinciroli P, Callari M, Carcangiu ML, Lorusso D,
Raspagliesi F, Pala V, et al: Involvement of AF1q/MLLT11 in the
progression of ovarian cancer. Oncotarget. 8:23246–23264. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Park J, Kim S, Joh J, Remick SC, Miller
DM, Yan J, Kanaan Z, Chao JH, Krem MM, Basu SK, et al: MLLT11/AF1q
boosts oncogenic STAT3 activity throughSrc-PDGFR tyrosine kinase
signaling. Oncotarget. 7:43960–43973. 2016.PubMed/NCBI
|
|
51
|
Carlsson E, Ranki A, Sipilä L, Karenko L,
Abdel-Rahman WM, Ovaska K, Siggberg L, Aapola U, Ässämäki R, Häyry
V, et al: Potential role of a navigator gene NAV3 in colorectal
cancer. Br J Cancer. 106:517–524. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Li J, Gao X, Ji K, Sanders AJ, Zhang Z,
Jiang WG, Ji J and Ye L: Differential expression of CCN family
members CYR611, CTGF and NOV in gastric cancer and their
association with disease progression. Oncol Rep. 36:2517–2525.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Hu H, Li C, Cai S, Zhu C, Tian Y, Zheng J,
Hu J, Chen C and Liu W: Increased expression of pleiotrophin is a
prognostic marker for patients with gastric cancer.
Hepatogastroenterology. 61:1478–1482. 2014.PubMed/NCBI
|
|
54
|
Gu Y, Wang Q, Guo K, Qin W, Liao W, Wang
S, Ding Y and Lin J: TUSC3 promotes colorectal cancer progression
and epithelial-mesenchymal transition (EMT) through WNT/β-catenin
and MAPK signalling. J Pathol. 239:60–71. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Fan X, Zhang X, Shen J, Zhao H, Yu X, Chen
Y, Zhuang Z, Deng X, Feng H, Wang Y and Peng L: Decreased TUSC3
promotes pancreatic cancer proliferation, invasion and metastasis.
PLoS One. 11:e01490282016. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Vašíčková K, Horak P and Vaňhara P: TUSC3:
Functional duality of a cancer gene. Cell Mol Life Sci. 75:849–857.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Vedeld HM, Andresen K, Eilertsen IA,
Nesbakken A, Seruca R, Gladhaug IP, Thiis-Evensen E, Rognum TO,
Boberg KM and Lind GE: The novel colorectal cancer biomarkers CDO1,
ZSCAN18 and ZNF331 are frequently methylated across
gastrointestinal cancers. Int J Cancer. 136:844–853. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Louis SF and Zahradka P: Vascular smooth
muscle cell motility: From migration to invasion. Exp Clin Cardiol.
15:e75–e85. 2010.PubMed/NCBI
|
|
59
|
Yamaguchi H and Condeelis J: Regulation of
the actin cytoskeleton in cancer cell migration and invasion.
Biochim Biophys Acta. 1773:642–652. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Hitosugi T, Fan J, Chung TW, Lythgoe K,
Wang X, Xie J, Ge Q, Gu TL, Polakiewicz RD, Roesel JL, et al:
Tyrosine phosphorylation of mitochondrial pyruvate dehydrogenase
kinase 1 is important for cancer metabolism. Mol Cell. 44:864–877.
2011. View Article : Google Scholar : PubMed/NCBI
|
